Menorrhagia

Menorrhagia is an abnormally heavy and prolonged menstrual period at regular intervals. Causes may be due to abnormal blood clotting, disruption of normal hormonal regulation of periods or disorders of the endometrial lining of the uterus. Depending upon the cause, it may be associated with abnormally painful periods . (From the Wikpedia article Menorrhagia.)

Download PDF containing detailed information.

Recent Publications on Menorrhagia:
Iron deficiency, Helicobacter infection and gastritis. Despite elegant regulatory mechanisms, iron deficiency anemia (IDA)...	13th November, 2009	Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.	Acta Haematol. 2009;122(2-3):97-102. Epub 2009 Nov 10. DOI Direct Link
Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders. Abstract Objective. To gain knowledge about the utility of hysterectomy in...	11th November, 2009	Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.	Acta Obstet Gynecol Scand. 2009 Nov 10.
Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes. Levonorgestrel- (LNG) releasing intrauterine device (IUD) insertion...	10th November, 2009	Obstetrics and Gynecology Department, Dr. Lutfi Kirdar Kartal Research and	Fertil Steril. 2009 Nov 5. DOI Direct Link
Management of menorrhagia with hydrothermal endometrial ablation in 2 women with bicornuate uteri. The majority of second generation endometrial ablation techniques are...	10th November, 2009	Gynaecology Department, Benenden Hospital, Kent, England.	J Minim Invasive Gynecol. 2009 Nov-Dec;16(6):795-7. DOI Direct Link
Office Endometrial Ablation with Local Anesthesia Using the HydroThermAblator System: Comparison of Outcomes in Patients with Submucous Myomas with Those with Normal Cavities in 246 Cases Performed Over 5(1/2) Years. STUDY OBJECTIVE: To estimate the safety and efficacy of the...	10th November, 2009	Department of Obstetrics and Gynecology, Kaiser Permanente Medical Center,	J Minim Invasive Gynecol. 2009 Nov-Dec;16(6):700-7. DOI Direct Link
→View more research publications.

Press Releases About Menorrhagia:
FDA Approves Lysteda to Treat Heavy Menstrual Bleeding	13th November, 2009	U.S. Food and Drug Administration	SILVER SPRING, Md., Nov. 13 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual
FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users	1st October, 2009	Bayer HealthCare Pharmaceuticals	-- the need to change sanitary protection during the night(2) "Many women with heavy periods often suffer privately with their symptoms. And because approved effective non-surgical
Xanodyne's New Drug Application for the Treatment of Heavy Menstrual Bleeding (Menorrhagia) Accepted for Filing with a Priority Review Classification	2nd April, 2009	Xanodyne Pharmaceuticals, Inc.	NEWPORT, Ky., April 2 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted priority review status for its
Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 Studies of Proprietary Modified Release Oral Tranexamic Acid Product Candidate for Heavy Menstrual Bleeding	5th August, 2008	Xanodyne Pharmaceuticals, Inc.	NEWPORT, Ky., Aug. 5 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. announced today positive top line results in two pivotal Phase 3 clinical trials of its proprietary investigational product, a

BioNews Results for Menorrhagia:
FDA Approves Lysteda to Treat Heavy Menstrual Bleeding	Pharma Live:  Nov 20 2009 5:44PM Matching: menorrhagia
Xanodyne wins FDA approval for menorrhagia drug	Pharmacy Choice:  Nov 19 2009 2:12AM Matching: menorrhagia
Xanodyne wins FDA approval for menorrhagia drug	TradingMarkets:  Nov 18 2009 3:29PM Matching: menorrhagia
Tranexamic Acid Tablets Approved	Facts & Comparisons:  Nov 18 2009 6:45PM Matching: menorrhagia
Xanodyne Pharma gets US FDA nod for Lysteda to treat heavy menstrual bleeding	PharmaBiz:  Nov 18 2009 2:36PM Matching: menorrhagia
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Menorrhagia Patents:
US Patent No.	Title
7354928	Small molecule inhibitors targeted at Bcl-2
7425569	1H-pyrazoles useful in therapy
7427689	ErbB-2 selective small molecule kinase inhibitors
7432300	Gossypol co-crystals and the use thereof
7432304	Small molecule antagonists of Bcl-2 family proteins
→View more patents.

Companies working in the area of Menorrhagia from Bioportfolio's Biocorporate database :
Company Name
Metris Therapeutics Established in 1996, Metris now has several products in development. These are a treatment for endometriosis, a treatment for menorrhagia / dysmenorrhea, using a proprietary vaginal drug delivery... www.metris.co.uk/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Menorrhagia scientists - we have details of around 380 individuals working on Menorrhagia .